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Objectives This study was designed to determine which of the National Cholesterol Education Program or National Health and
Nutrition Examination Survey low- and high-density lipoprotein cholesterol classifications of dyslipidemia status in ado-
lescents is most effective at predicting high common carotid artery intima-media thickness (IMT) in adulthood.
Background Two classifications of pediatric dyslipidemia status have been proposed. No study has assessed which of these
is most effective for predicting adolescents who will develop preclinical atherosclerosis in adulthood.
Methods Three population-based, prospective cohort studies collected lipoprotein measurements on 1,711 adolescents
age 12 to 18 years who were remeasured as young adults age 29 to 39 years. Lipoproteins in adolescence were
classified according to National Cholesterol Education Program and National Health and Nutrition Examination
Survey cut points, and high IMT in adulthood was defined as those at or above the age-, sex-, race-, and cohort-
specific 90th percentile of IMT.
Results Independent of the classification employed, adolescents with dyslipidemia were at significantly increased risk of hav-
ing high IMT in adulthood (relative risks from 1.6 to 2.5). Differences in predictive capacity between both classifica-
tions were minimal. Overweight or obese adolescents with dyslipidemia had increased carotid IMT (males: 0.11 mm;
females: 0.08 mm) in adulthood compared with those who did not have both risk factors. Adolescent dyslipidemia
status was more strongly associated with high IMT in adulthood than change in dyslipidemia status.
Conclusions Pediatric dyslipidemia classifications perform equally in the prediction of adolescents who are at increased risk of
high IMT in young adulthood. Our data suggest that dyslipidemia screening could be limited to overweight or obese
adolescents. (J Am Coll Cardiol 2009;53:860–9) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.09.061A
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March 10, 2009:860–9 Pediatric Lipid Classifications and Adult IMTalling for its revision (7). One area of the existing guidelines
utlined for revision includes the lipid and lipoprotein cut
oints used to assign risk status. Dichotomous cut points for
isk stratification aim to define those who are at an increased
isk of developing clinically significant atherosclerotic cardio-
ascular disease (ASCVD), and in whom risk modification will
educe the risk of subsequent complications. Studies that
emonstrate this association between proposed pediatric dys-
ipidemia cut points and clinical outcomes such as myocardial
nfarction are lacking, due to the long latency of ASCVD. In
he absence of “hard” clinical outcomes, noninvasive imaging
echniques that have been shown to predict adult ASCVD
such as ultrasound to examine carotid artery intima-media
hickness [IMT]) provide a surrogate end point to assess early
therosclerosis (8).
See page 870
Two classifications of adolescent dyslipidemia have been
irculated. One is a fixed-point classification of dyslipi-
emias for children and adolescents aged 2 to 19 years that
ere stipulated by NCEP and are currently used in existing
onsensus guidelines (6,7). The other is a recently proposed
et of age- and sex-specific cut points for adolescents aged
2 to 19 years that were derived from growth curve data of
National Health and Nutrition Examination Surveys
NHANES) and linked to established dyslipidemia thresh-
lds for adults (3). We have previously compared the ability
f these classifications to predict dyslipidemia in adulthood
9). In this study, we used data from 3 prospective cohort
tudies commencing in adolescence to: 1) determine which
f the NCEP or NHANES adolescent low-density lipopro-
ein cholesterol (LDL-C) and high-density lipoprotein
holesterol (HDL-C) dyslipidemia classifications best pre-
ict high common carotid IMT in adulthood; and 2) to
ssess whether maintaining or changing dyslipidemia status
rom adolescence to adulthood has an effect on carotid IMT
easured in adulthood.
ethods
ollowing is an abbreviated version of the methodology, for
full description, please see the Online Appendix. Each of
he 3 studies described received ethical approval and ob-
ained written informed consent from participants.
innish Data:
he Cardiovascular Risk in Young Finns Study
tudy sample. This study sample is described in detail
lsewhere (10). In this study, we included 1,171 subjects
66% of those eligible, 45% male) who were age 12, 15, and
8 years at baseline and who had LDL-C and HDL-C data
rom 1980 and carotid artery ultrasonography data in 2001.
linic measurements. Serum cholesterol and triglycerideoncentrations were determined using enzymatic methods i11). HDL-C was analyzed after
recipitation of very low-density
ipoprotein and LDL-C with
extran sulfate 500,000 (11).
rotocols for baseline measures
f blood pressure, body mass in-
ex (BMI), and cigarette smok-
ng have been described else-
here (12).
arotid artery ultrasound
tudies. B-mode ultrasound stud-
es of the left carotid artery were
erformed at follow-up using
tandardized protocols that have
een described previously (12).
t least 4 measurements of the
ar wall were taken approxi-
ately 10 mm proximal to the
ifurcation to derive mean and
aximum carotid IMT. The av-
rage absolute difference and
tandard deviation between measurements for 57 partici-
ants who underwent repeat ultrasound examinations was
.05  0.04 mm.
.S. Data: The Bogalusa Heart Study
tudy sample. This study sample has been described in
etail elsewhere (13). For this study, 254 participants (17%
f those eligible from the 1984 to 1985 survey, 44% male,
0% African American) age 12 to 17 years at baseline who
ad LDL-C and HDL-C measures from baseline (1984 to
985) and carotid artery ultrasound at follow-up (2001 to
002) were included.
linic measurements. In 1984 to 1985, serum cholesterol
nd triglyceride levels were measured with a Technicon
uto Analyzer II (Technicon Instrument Corp., Tarry-
own, New York), according to the laboratory manual of the
ipid Research Clinics program (14). In 2001 to 2002,
erum cholesterol and triglycerides levels were deter-
ined by enzymatic procedures. Serum lipoprotein cho-
esterol levels were analyzed using a combination of
eparin-calcium precipitation and agar-agarose gel elec-
rophoresis procedures (15). Baseline measures of blood
ressure, BMI, and cigarette smoking have been de-
cribed in detail previously (16).
arotid artery ultrasound studies. B-mode ultrasound
xaminations were performed according to protocols
reviously described (17). Maximum IMT measurements
ere taken from both left and right common carotid,
arotid bifurcation, and internal carotid segments accord-
ng to strict protocols (18). The average absolute differ-
nce and standard deviation between measurements for
5 participants who underwent repeat ultrasound exam-
Abbreviations
and Acronyms
ASCVD  atherosclerotic
cardiovascular disease
AUC  area under the
receiver-operator
characteristic curve
BMI  body mass index
HDL-C  high-density
lipoprotein cholesterol
IMT  intima-media
thickness
LDL-C  low-density
lipoprotein cholesterol
NCEP  National
Cholesterol Education
Program
NHANES  National Health
and Nutrition Examination
Surveynations was 0.05  0.03 mm.
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Pediatric Lipid Classifications and Adult IMT March 10, 2009:860–9ustralian Data: The CDAH
Childhood Determinants of Adult Health) Study
tudy sample. This study sample has been described in
etail elsewhere (9,19). In this study, we include data from
86 participants (26% of those eligible from baseline, 50%
ale) aged 12 and 15 years at baseline who had LDL-C and
DL-C data from 1985 and carotid artery ultrasound
easures at follow-up (2004 to 2006).
linic measurements. In 1985, serum total cholesterol and
riglycerides were determined according to the Lipids Re-
earch Clinic Program (14), and HDL-C analyzed follow-
ng precipitation of apolipoprotein-B–containing lipopro-
eins with heparin-manganese (19). In the period from 2004
o 2006, serum total cholesterol, triglyceride, and HDL-C
oncentrations were determined enzymatically (9). The
DL-C concentration was calculated using the Friedewald
ormula (20). Baseline measurements of blood pressure,
MI, and smoking habits were collected according to
rotocols presented elsewhere (19).
arotid artery ultrasound studies. B-mode ultrasound
tudies of the carotid artery were performed using a portable
cuson Cypress (Siemens Medical Solutions USA Inc.,
ountainview, California) ultrasound machine with a 7.0-
Hz linear-array transducer by a single technician. We
ave previously demonstrated that vascular measurements
erived from this machine compare well with those from a
linic-based machine (21). The ultrasound technician fol-
owed carotid artery imaging protocols described by the
ardiovascular Risk in Young Finns study (12). Six mea-
urements of the common carotid far wall were taken
pproximately 10 mm before the border of the carotid bulb
o derive mean and maximum carotid IMT. The average
bsolute difference and standard deviation between mea-
urements for 30 participants who had replicate maximum
MT measurements was 0.02  0.04 mm.
lassification of Dyslipidemia
tatus in Adolescence and Adulthood
he NCEP (7) and NHANES (3) pediatric cut points were
sed to assign adolescent LDL-C and HDL-C status
Online Tables 1A and 1B). At follow-up, NCEP adult
reatment panel guidelines were used to classify participants
s nondyslipidemic (4.14 mmol/l; 160 mg/dl) or dys-
ipidemic (4.14 mmol/l;160 mg/dl) LDL-C status, and
ondyslipidemic (1.036 mmol/l; 40 mg/dl) or dyslipi-
emic (1.036 mmol/l; 40 mg/dl) HDL-C status (22).
arotid IMT Measurements and
lassification of High Carotid IMT in Adulthood
or the analyses, we chose the most consistent IMT
easurement across the 3 study sites, which incorporated
he maximum measurement at the far wall of the left
ommon carotid artery (Online Table 2, Online Fig. 1).
lthough no consensus clinical definition of high carotid bMT currently exists for young adults, we defined high IMT
n adulthood as a maximum IMT90th percentile for age-,
ex-, race- (Bogalusa), and cohort-specific values. The
pecific values used to denote high IMT are provided in
nline Table 3.
tatistical Analyses
omparisons between baseline characteristics of partici-
ants and nonparticipants at follow-up within each cohort
ere performed using logistic regression.
omparison of NCEP versus NHANES adolescent dys-
ipidemia classifications. Logarithmic-binomial regres-
ion was used to estimate the relative risk of high IMT at
ollow-up for various baseline lipoprotein classifications
23). Estimates were adjusted for age at baseline, sex, race
for the Bogalusa data only), and length of follow-up. We
djusted for length of follow-up to account for within-
ohort differences observed between length of follow-up and
isk of high IMT in both the CDAH and Bogalusa studies.
or pooled estimates, we additionally adjusted for cohort to
ccount for differences in lipoprotein determination meth-
ds between the 3 cohorts. We also considered baseline
MI status (normal weight vs. overweight/obese in adoles-
ence) (24) as a potential confounding variable in these
nalyses. The analyses for NCEP and NHANES HDL-C
lassifications were stratified by BMI status due to effect
odification.
The ability of each adolescent LDL-C and HDL-C
lassification to predict high IMT in adulthood was assessed
sing sensitivity, specificity, positive predictive value, nega-
ive predictive value, and area under receiver-operator char-
cteristic curves (AUC). Tests for significant differences
etween AUC were calculated using the DeLong algorithm
25). This method assumes the correct null distribution
hen there are only 3 classification levels (i.e., normal-,
orderline-, and high-risk groups), as is the case here.
nalyses were stratified by BMI status owing to effect
odification.
hange in dyslipidemia status and high IMT in adult-
ood. A change variable was created that divided partic-
pants into 4 categories depending on their lipoprotein
tatus at both time points. Participants were classified as
persistent nondyslipidemia,” “nondyslipidemia to dyslip-
demia,” “dyslipidemia to nondyslipidemia,” and “persis-
ent dyslipidemia.” Their adolescent lipoprotein status
as determined using what we judged to be the best
erforming LDL-C and HDL-C pediatric dyslipidemia
lassifications for predicting adult IMT, ascertained from
he above-mentioned comparison analyses. Logarithmic-
inomial regression was used to estimate the relative risk
f high carotid IMT in adulthood depending on the
hange variable. These analyses were performed for
ooled data only and are presented adjusted for age at
aseline, sex, cohort, and length of follow-up in Model 1,
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March 10, 2009:860–9 Pediatric Lipid Classifications and Adult IMTnd with additional adjustments for BMI at baseline,
ystolic blood pressure at baseline, and smoking status at
aseline in Model 2. Interaction between the model
ariables was tested; no significant interactions were
ound.
To complement the categorical analyses, we also ex-
mined the effect of change in the continuous lipoprotein
evels on the continuous outcome measure of IMT using
inear regression. We adopted the life-course analysis
pproach described by De Stavola et al. (26), with the
dolescent lipoprotein variable and change in the lipopro-
ein variable (derived as the difference between adult and
dolescent lipoprotein levels) used as predictor variables.
he regression coefficient for the adolescent lipoprotein
ariable quantifies the total effect, that is, the sum of
irect and indirect (mediated via adult lipoprotein levels
ue to tracking) (27) effects of adolescent LDL-C or
ean Values for Adolescent and Adult Characteristics in Those Wiithout IMT >90th Per ile in Adulthood in Cohorts From Finlan
Table 1 Mean Values for Adolescent and Adult CharacteristicsWithout IMT >90th Percentile in Adulthood in Cohorts
Cohort
Males
IMT <90th
Percentile
IMT >90th
Percentile
Young Finns
Adolescence
n 469 54
Age, yrs 15.0 2.4 14.8 2.4
LDL-C, mmol/l 3.22 0.78 3.49 0.84
HDL-C, mmol/l 1.50 0.31 1.49 0.33
Adulthood
Age, yrs 36.0 2.4 35.8 2.4
LDL-C, mmol/l 3.63 0.92 3.84 0.83
HDL-C, mmol/l 1.18 0.28 1.15 0.31
IMT, mm 0.64 0.08 0.87 0.11
Bogalusa
Adolescence
n 98 13
Age, yrs 14.8 1.6 14.9 1.9
LDL-C, mmol/l 2.39 0.72 2.62 0.67
HDL-C, mmol/l 1.44 0.52 1.17 0.54
Adulthood
Age, yrs 31.8 1.5 32.2 1.6
LDL-C, mmol/l 3.21 0.81 3.50 0.66
HDL-C, mmol/l 1.09 0.27 1.15 0.37
IMT, mm 0.73 0.11 1.06 0.11
CDAH
Adolescence
n 119 24
Age, yrs 13.4 1.5 13.1 1.5
LDL-C, mmol/l 2.61 0.56 2.73 0.67
HDL-C, mmol/l 1.38 0.26 1.45 0.35
Adulthood
Age, yrs 33.4 1.7 32.9 1.6
LDL-C, mmol/l 3.21 0.71 3.26 0.75
HDL-C, mmol/l 1.27 0.29 1.33 0.30
IMT, mm 0.60 0.08 0.80 0.08tatistics are mean  SD. To convert LDL-C and HDL-C to mg/dl, multiply values by 38.67.
CDAH  Childhood Determinants of Adult Health Study; HDL-C  high-density lipoprotein cholesterol;DL-C on IMT, whereas the regression coefficient for
hange in lipoprotein levels quantifies the additional gain
rom increasing or decreasing lipoprotein levels by 1
mol/l between adolescence and adulthood relative to
articipants with the same adolescent lipoprotein level,
ut whose lipoprotein level was unchanged. Multivariable
odels were specified, including adolescent LDL-C and
hange in LDL-C, and adolescent HDL-C and change
n HDL-C. All models were adjusted for age at baseline,
ex, cohort, length of follow-up, baseline BMI, baseline
ystolic blood pressure, and baseline smoking status. The
ssumption of linearity in the regression models of
he continuous predictor variables was checked using the
ethod of fractional polynomials (28). The analyses are
resented stratified by adolescent BMI status due to
ffect modification. The distribution of IMT values were
ight-skewed; however, for ease of interpretation and
de U.S., and Australia
ose With and
Finland, the U.S., and Australia
Females
All
IMT <90th
Percentile
IMT >90th
Percentile
566 82 1,171
14.8 2.4 15.0 2.5 14.9 2.4
3.34 0.79 3.39 0.79 3.30 0.79
1.59 0.29 1.57 0.29 1.55 0.30
35.8 2.4 36.0 2.5 35.9 2.4
3.25 0.78 3.35 0.80 3.43 0.87
1.40 0.30 1.37 0.31 1.30 0.31
0.61 0.07 0.79 0.06 0.65 0.10
128 15 254
14.8 1.5 14.7 1.3 15.3 1.5
2.48 0.61 2.76 0.67 2.47 0.66
1.56 0.49 1.32 0.39 1.48 0.51
31.9 1.5 31.9 1.2 32.4 1.4
3.03 0.89 3.39 0.83 3.15 0.85
1.28 0.35 1.22 0.49 1.20 0.34
0.67 0.09 0.92 0.08 0.73 0.14
131 12 286
13.4 1.5 13.3 1.5 13.4 1.5
2.67 0.63 3.58 1.58 2.69 0.69
1.50 0.28 1.36 0.38 1.44 0.29
33.4 1.6 32.9 1.8 33.3 1.7
2.79 0.80 3.96 2.17 3.05 0.90
1.57 0.36 1.57 0.33 1.43 0.36
0.59 0.07 0.78 0.05 0.62 0.10th and, th
in Th
FromIMT  intima-media thickness; LDL-C  low-density lipoprotein cholesterol.
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Pediatric Lipid Classifications and Adult IMT March 10, 2009:860–9omparability with previous studies in young adults, we
sed nontransformed IMT values. Using logarithmic-
ransformed IMT values made little difference to the
esults presented.
esults
haracteristics of participants and nonparticipants. Non-
articipation in those eligible for follow-up measures (34%
oung Finns, 82% Bogalusa, 67% CDAH) was more likely
n males and those of younger age in each cohort and more
ikely in African Americans in the Bogalusa cohort. There
ere no statistically or clinically significant differences in
DL-C or HDL-C levels or LDL-C or HDL-C dyslipi-
emia status between participants and nonparticipants in
ny of the 3 cohorts (data not shown).
dolescent and adult characteristics by carotid IMT
tatus. Mean values for key baseline and follow-up
ariables are displayed in Table 1 for males and females in
ach cohort who had IMT 90th percentile and IMT
90th percentile (see Online Table 3 for values in
illigrams per deciliter). Across each sex and cohort,
hose with high IMT at follow-up tended to have higher
DL-C levels during adolescence and adulthood. Boga-
usa participants and females in the CDAH study with
igh IMT had lower HDL-C levels during adolescence
ut not at follow-up.
omparison of NCEP versus NHANES cut points. The
revalence of adolescent LDL-C dyslipidemia was 32.3%
or NCEP or 19.6% for NHANES cut points. High-
ensity lipoprotein cholesterol dyslipidemia was prevalent in
.5% of adolescents using NCEP cut points or 6.1% of
dolescents using NHANES cut points. Pooled data
howed that the risk of having high IMT in adulthood was
ignificantly higher in those with borderline- and high-risk
DL-C levels in adolescence compared with those with
ormal levels using NHANES cut points (Fig. 1A). Use of
CEP LDL-C cut points showed only those with high-risk
evels in adolescence had significantly increased risk of high
MT in adulthood compared with those classified as nor-
al, although the borderline-risk group showed a nonsig-
ificant trend toward increased risk (Fig. 1A). A graded
ncrease in the risk of having high IMT in adulthood was
bserved when moving from normal, to borderline-risk, to
igh-risk groups for NCEP and NHANES LDL-C cut
oints (Fig. 1A).
Normal-weight adolescents with NCEP classified high-
isk (low) HDL-C were at significantly increased risk of
aving IMT90th percentile at follow-up (Fig. 1B). There
as no increased risk of having high IMT at follow-up for
ormal-weight adolescents classified as borderline-risk
DL-C levels using either classification or for those with
igh-risk HDL-C levels according to NHANES cut points
Fig. 1B). For overweight or obese adolescents, the risk of
igh IMT in adulthood was significantly increased in those
ith borderline- or high-risk HDL-C levels compared withFigure 1 Relative Risks for High IMT in Adulthood
According to NCEP and NHANES Cut Points
Relative risks for high IMT (90th percentile) in adulthood according to NCEP
and NHANES for (A) LDL cholesterol dyslipidemia status, (B) HDL cholesterol
dyslipidemia status in normal-weight adolescents, and (C) HDL cholesterol dys-
lipidemia status in overweight/obese adolescents. Relative risks and 95% con-
fidence intervals adjusted for age, sex, cohort, and length of follow-up. HDL 
high-density lipoprotein; IMT  intima-media thickness; LDL  low-density
lipoprotein; NCEP  National Cholesterol Education Program; NHANES 
National Health and Nutrition Examination Survey.
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March 10, 2009:860–9 Pediatric Lipid Classifications and Adult IMThose who had normal levels using either pediatric classifi-
ation (Fig. 1C). The relative risks were similar for over-
eight or obese adolescents with borderline- or high-risk
DL-C levels. When data where not stratified by BMI
tatus, only those with high-risk HDL-C were at signifi-
antly increased risk of having high IMT at follow-up
NCEP: relative risk [RR]: 2.5, 95% confidence interval
CI]: 1.4 to 4.6; NHANES: RR: 1.6, 95% CI: 1.0 to 2.7).
Diagnostic performance statistics comparing NCEP and
HANES classifications are presented in Table 2. The
CEP high-risk LDL-C cut points were more sensitive but
ess specific than the NHANES cut points. Although this
rend in sensitivity and specificity was consistent across
ohorts, heterogeneity in the point estimates between co-
orts was observed (data not shown). False positives were
igh for both LDL-C classifications in normal weight
dolescents with 87% of those with high levels not devel-
ensitivity, Specificity, PPV, NPV, and AUC Data of NCEP and NHAorderline- and High-Risk Lipoprotei Variable Cut Points to Predic
Table 2 Sensitivity, Specificity, PPV, NPV, and AUC Data of NCBorderline- and High-Risk Lipoprotein Variable Cut Poin
Dyslip
Borderline Risk
Lipoprotein Variable Classification Sensitivity Specificity PPV
Normal weight
LDL cholesterol NCEP 64.8‡ 44.0 12.2
NHANES 50.6 56.6‡ 12.2
HDL cholesterol NCEP 53.7 43.9 10.3
NHANES 52.5 47.0‡ 10.6
Overweight/obese
LDL cholesterol NCEP 63.2‡ 52.0 24.7
NHANES 55.3 59.2‡ 25.3
HDL cholesterol NCEP 92.1 30.5 24.6
NHANES 89.5 30.5 24.1
ensitivity  true positives/(true positives  false negatives)  100. Specificity  true negatives/
PV true negatives/(true negatives false negatives) 100. *Normal-, borderline-, and high-ris
etween sensitivities and specificities.
AUC  area under the receiver-operator characteristic curve; NCEP  National Cholesterol Educ
alue; PPV  positive predictive value; other abbreviations as in Table 1.
ensitivity, Specificity, PPV, NPV, and AUC Data for Combining NCEPut Points to Other Risk Factors Present in Adolescence to Predic
Table 3 Sensitivity, Specificity, PPV, NPV, and AUC Data for ComCut Points to Other Risk Factors Present in Adolescen
Lipoprotein Variable Screening Strategy
LDL cholesterol
Universal
Overweight†  NCEP cut points
Hypertension‡  NCEP cut points
Smoking§  NCEP cut points
Overweight† or hypertension‡  NCEP cut points
HDL cholesterol
Universal
Overweight†  NCEP cut points
Hypertension‡  NCEP cut points
Smoking§  NCEP cut points
Refers to the total number of participants that would be screened. †Overweight or obese dete
Hypertension defined according to pediatric cut points from the National High Blood Pressure
igarette smoking on a weekly basis or more often. Family history was considered but not included i
e found family history in Young Finns did not appreciably add to the prediction of adolescents with adu
Abbreviations as in Tables 1 and 2.ping high IMT in young adulthood. Sensitivity, positive
redictive value, and AUC values increased when
orderline- and high-risk HDL-C cut points were applied
o overweight or obese adolescents (Table 2), but remained
ow overall. The diagnostic performance characteristics were
imilar for both classifications of adolescent HDL-C. We
ote that AUC using other age-, sex-, and cohort-specific
ut points of IMT (70th, 75th, 80th, 85th, 90th, and 95th
ercentiles) in our data did not appreciably modify the
esults presented (data not shown). Diagnostic statistics of
dolescents with other risk factors including hypertension
nd cigarette smoking in addition to the NCEP dyslipide-
ia cut points are displayed in Table 3. The addition of
ypertension to the LDL-C cut points improved the pre-
iction of those with high IMT in adulthood (29). The
rediction was comparable to those who were overweight
nd did not improve further when either hypertension or
Classifications for Adolescenth Carotid IMT in Adulthood
nd NHANES Classifications for Adolescent
Predict High Carotid IMT in Adulthood
Status in Adolescence
High Risk
PV Sensitivity Specificity PPV NPV AUC* p Value†
1.3 38.9‡ 68.7 12.9 90.4 0.55
0.6 23.5 80.7‡ 12.7 89.8 0.55 0.73
8.8 3.1 98.8‡ 22.7 89.5 0.49
9.2 4.9 95.4 11.4 89.4 0.49 0.69
4.9 50.0‡ 70.4 29.7 84.9 0.60
4.1 34.2 85.5‡ 37.1 83.4 0.63 0.33
4.0 15.8 90.3‡ 28.6 81.3 0.62
2.2 26.3 83.8 28.6 82.2 0.62 0.88
egatives  false positives)  100. PPV  true positives/(true positives  false positives)  100.
ed in AUC analyses as 3 groups. †Test for difference between AUCs. ‡McNemar test for difference
rogram; NHANES  National Health and Nutrition Examination Survey; NPV  negative predictive
-Risk Lipoprotein Variableh Carotid IMT i Adulthood
g NCEP High-Risk Lipoprotein Variable
Predict High Carotid IMT in Adulthood
* Sensitivity Specificity PPV NPV AUC
07 41.0 68.9 14.9 89.8 0.56
90 50.0 70.4 29.7 84.9 0.60
55 45.3 71.2 21.6 88.1 0.61
18 30.3 79.5 20.8 86.5 0.54
91 43.4 71.6 21.9 87.4 0.60
10 5.5 97.8 25.6 88.7 0.53
92 15.8 90.3 28.6 81.3 0.62
55 7.6 99.3 66.7 86.0 0.54
18 9.1 96.8 33.3 85.6 0.52
according to International Obesity Task Force body mass index cut points for pediatrics (24).
on Program (29). §Participants were classified as smokers at baseline if they indicated regular
analyses owing to divergence in the definitions of positive history among the 3 cohorts. Previously,NESt Hig
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oints.
ffect of change in dyslipidemia status on high IMT. For
he analyses of change in lipoprotein status between adoles-
ence and adulthood, we used the NHANES classification
o assign adolescent LDL-C dyslipidemia status and the
CEP classification to assign adolescent HDL-C dyslipi-
emia status. In Table 4, we present pooled relative risks of
aving a high IMT in young adulthood according to
DL-C and HDL-C dyslipidemia status during adoles-
ence and adulthood. A change in LDL-C status from
ondyslipidemia to dyslipidemia or dyslipidemia to nondys-
ipidemia did not significantly increase the risk of high IMT
ompared with those who remained normal at both times.
hose with LDL-C dyslipidemia at both times had signif-
cantly increased risk of high IMT in adulthood than those
ith persistently normal levels. Analysis of continuous data
howed that participants with higher baseline levels of
DL-C had higher IMT as adults (regression coefficient for
1 standard deviation [SD] increase: 0.014, p  0.001).
here was some evidence that those who increased LDL-C
evels between adolescence and adulthood had higher IMT
t follow-up, but this effect was not statistically significant
regression coefficient for a 1 SD increase: 0.005, p  0.08).
For HDL-C, the relative risk of having a high IMT in
dulthood was significantly increased for participants who
ad low (dyslipidemic) levels in adolescence irrespective of
heir adult levels (Table 4). The relative risk of high IMT in
he nondyslipidemia to dyslipidemia group was similar to
hat of the persistent nondyslipidemia group. Only a small
umber of participants moved from dyslipidemia to non-
yslipidemia, so the data for this group should be inter-
reted with caution. Analyses of continuous data showed
vidence that higher HDL-C levels in overweight or obese
dolescents were associated with lower IMT in adulthood
regression coefficient for a 1 SD increase: –0.011, p 
.01), whereas change in HDL-C between adolescence and
elative Risks From Pooled Data for the Effect of Change in LDL-C antatus Between Adolescence and Adulthood on Carot d Artery IM
Table 4 Relative Risks From Pooled Data for the Effect of ChangStatus Between Adolescence and Adulthood on Caro
Lipoprotein Status in Adolescence and Adulthood
M
n/N* %
LDL-C
Persistent nondyslipidemia 127/1,206 10.5
Nondyslipidemia to dyslipidemia 19/143 13.3
Dyslipidemia to nondyslipidemia 25/205 12.2
Persistent dyslipidemia 25/124 20.2
HDL-C
Persistent nondyslipidemia 143/1,303 11.0
Nondyslipidemia to dyslipidemia 45/358 12.6
Dyslipidemia to nondyslipidemia 4/16 25.0
Persistent dyslipidemia 7/27 25.9
odel 1 was adjusted for age at baseline, sex, cohort, and length of follow-up. Model 2 was addition
Number of participants with high IMT/all participants. †Sample sizes differ between Models 1 a
CI  confidence interval; Ref  reference group; RR  relative risk; other abbreviations as in Tdulthood was not. In normal-weight adolescents, analyses lf continuous data showed no association between baseline
r change in HDL-C levels and IMT in adulthood. In
ultivariable analyses that included adolescent and change
ariables for LDL-C and HDL-C in the model, baseline
ipoprotein levels were generally stronger predictors of IMT
han changes in levels between adolescence and adulthood
Fig. 2).
Based on this model, we predicted the level of IMT at 35
ears of age for normal-weight and overweight or obese
dolescents, with normal and dyslipidemic levels of LDL-C
nd HDL-C at age 15 years (Fig. 3). The difference in IMT
t age 35 years for normal-weight adolescents with and
ithout dyslipidemia was minimal. IMT at age 35 years for
hose who were overweight or obese as adolescents and did
ot have dyslipidemia were comparable with IMT for
ormal-weight adolescents. Overweight or obese adoles-
ents with dyslipidemia had markedly higher IMT at age 35
ears than the other groups (Fig. 3).
iscussion
n this study, we sought to determine whether 2 classifica-
ions of pediatric dyslipidemia (NCEP vs. NHANES)
redicted IMT in adulthood and which of these would be
ost effective in identifying adolescents at high risk of
ncreased IMT as adults. We found that both dyslipidemia
ut points were able to predict those with high IMT in
dulthood, but our data did not provide a clear indication of
hich LDL-C and HDL-C cut points should be preferred
y those who wish to identify adolescents with lipid disor-
ers. Given that there were no substantial differences in the
iagnostic performance of the classifications, the simplicity
n applying the fixed NCEP cut points may offer an
dvantage over the age- and sex-specific NHANES cut
oints in a clinical or research setting. Importantly, users of
ither classification need to be mindful that most adoles-
ents identified with dyslipidemic LDL-C and HDL-C
nge in HDL-C90th Percentile
DL-C and Change in HDL-C
rtery IMT >90th Percentile
Model 2
RR 95% CI n/N*† % RR 95% CI
1.0 Ref 121/1,148 10.5 1.0 Ref
1.3 0.8–2.1 16/136 11.8 1.2 0.8–1.9
1.2 0.8–1.9 23/191 12.0 1.2 0.7–1.9
2.1 1.4–3.1 24/117 20.5 2.0 1.4–3.0
1.0 Ref 135/1,234 10.9 1.0 Ref
1.2 0.9–1.7 41/338 12.1 1.2 0.8–1.6
2.6 1.0–6.5 4/15 26.7 2.8 1.1–6.9
2.6 1.3–5.2 7/27 25.9 2.1 1.1–4.3
usted for baseline body mass index, baseline smoking status, and baseline systolic blood pressure.
ing to missing baseline data on smoking and/or systolic blood pressure in some participants.d ChaT >
e in L
tid A
odel 1
ally adjevels will not be at or above the 90th percentile for carotid
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MT will not be identified by using lipoprotein levels in
dolescence. Discrimination was considerably better for
verweight or obese adolescents compared with their
ormal-weight peers, which does support targeted, rather
han universal (whole- or random-population), screening
trategies endorsed in current guidelines (2,6,7).
Single adolescent measures of LDL-C and HDL-C in
his study were stronger predictors of adult IMT than
hange between adolescence and adulthood. Although a
eneficial change in lipoprotein levels did show trends
oward lower IMT in adulthood, particularly for those who
ere overweight or obese as adolescents, the magnitude of
Figure 2
Regression Coefficients for Associations of
Adolescent LDL-C and HDL-C, and Change in
LDL-C and HDL-C With Carotid IMT in Adulthood
Regression coefficients for associations of adolescent LDL-C, change in LDL-C
between adolescence and adulthood, adolescent HDL-C, and change in HDL-C
with carotid IMT in adulthood for (A) normal-weight and (B) overweight or
obese adolescents. Regression coefficients and their 95% confidence intervals
are adjusted for age at baseline, sex, cohort, length of follow-up, systolic blood
pressure at baseline, and smoking status at baseline. Regression coefficients
expressed in millimeters for 1 standard deviation change in the continuous
variables. Adolescent LDL-C, HDL-C, and change in LDL-C and HDL-C variables
were included in the same multivariable model. HDL-C  HDL cholesterol;
LDL-C  LDL cholesterol; other abbreviations as in Figure 1.his effect was smaller than for the baseline measure.oreover, based on our predictive modeling (Fig. 3), the
egree of IMT difference at age 35 years between over-
eight or obese 15 year olds with LDL-C dyslipidemia and
DL-C dyslipidemia compared with normal-weight 15
ear olds with normal LDL-C and HDL-C levels was
linically significant (8) (males: 0.11 mm; females: 0.08
m) and more than would be expected from measurement
rror alone.
Taken together, our and others’ data (12,30,31) clearly
how the importance of adolescent lipid levels as a predictor
f pre-clinical atherosclerosis and provide some epidemio-
ogical rationale for recent recommendations for pediatric
ipid screening released in July 2008 (6). However, the
fficacy of screening for dyslipidemia in a general population
sing NCEP or NHANES classifications as a way to
dentify adolescents at risk of ASCVD has considerable
imitations (as indicated), particularly for clinic use. For
ormal-weight adolescents, population-wide primary pre-
ention programs that target LDL-C levels, such as those
sed in the DISC (Dietary Intervention Study in Children)
nd STRIP (Special Turku Coronary Risk Factor Interven-
ion Project for Children) studies (32,33), and maintenance
f healthy weight may be most practical. Lipid screening in
he general pediatric population could be limited to adoles-
ents who have other CVD risk factors such as obesity or
ypertension to further stratify the risk of this group.
tudy limitations. This study has a number of potential
imitations. First, there was heterogeneity in the IMT
ocation and ultrasound protocols between cohorts. Even
hough we attempted to take this heterogeneity into account
y defining high IMT according to age-, sex-, race- (Bo-
alusa), and cohort-specific values, we note that attempts by
uture investigators to merge imaging studies for statistical
Figure 3
Least Square Means of Carotid IMT at
Age 35 Years for Males and Females by BMI
Status and Dyslipidemia Status at Age 15 Years
Least square means are adjusted for length of follow-up, cohort, change in
LDL-C, change in HDL-C, baseline smoking status, and baseline systolic blood
pressure. Abbreviations as in Figures 1 and 2.
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tandardization are heeded (8). Second, 1 explanation for
he poor diagnostic performance of the dyslipidemia classi-
cations in this study may have been due to differing
ethods of lipoprotein determination between NCEP/
HANES samples and our cohorts. Lipoprotein levels,
articularly HDL-C, have been shown to differ depending
n which methodology is used (34). Third, because we only
ad data from 2 time points, we were unable to account for
ultiple changes that may have occurred in the intervening
eriod or the timing of these changes. Moreover, use of only
lipoprotein measurement at each time point may have
ontributed to misclassification of some participants (27),
hich would likely lead to an underestimate of the predic-
ion estimates in this study (35). Fourth, we were unable to
ccount for the potential role of pubertal status as a
onfounding variable, because data were not available for all
ohorts. We performed sensitivity analyses with Young
inns data to adjust for pubertal status. The coefficients
ere generally unchanged from those analyses where age
djustment was used. Fifth, poorer image quality in ultra-
ound scans (assessed subjectively in the Young Finns and
DAH studies) was associated with higher BMI (r  0.11)
nd could bias carotid IMT readings in overweight or obese
ndividuals. Sensitivity analyses adjusting for image quality
ielded similar results to those presented. Finally, our data
re from population-based cohorts and may not be gener-
lizable to other higher-risk patients, such as those with
iabetes mellitus or a strong family history of premature
VD.
onclusions
ur data indicate that dyslipidemic lipoprotein levels in ado-
escence are associated with an increased risk of high IMT in
oung adulthood; that the predictive capacity of both NCEP
nd NHANES cut points are similar and could be applied for
ipid screening with equal success; that adolescent lipid levels
re more strongly associated with high IMT in adulthood than
hange in lipid levels; and that dyslipidemia in the presence of
verweight or obesity places affected adolescents at substan-
ially higher risk of increased IMT as adults compared with
hose who do not have both risk factors. These data underscore
he importance of both population-wide and individualized
revention programs to improve pediatric dyslipidemia-related
auses of early atherosclerosis.
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